Patrizia Cavazzoni, who served as the FDA’s Director of the Center for Drug Evaluation and Research (CDER) joined as Pfizer’s (NYSE: PFE) Chief Medical Officer in February, while Peter Marks ...

— Director of FDA’s drug center, Dr. Patrizia Cavazzoni, who stepped down days before President Donald Trump took office. — The agency’s second-ranking official. Dr.

Director of FDA’s drug center, Dr. Patrizia Cavazzoni, who stepped down days before President Donald Trump took office. The agency’s second-ranking official. Dr.

— The director of FDA’s drug center, Dr. Patrizia Cavazzoni, who stepped down days before President Donald Trump took office.

AFP via Getty Images Marks’ resignation comes about two months after the exit of Patrizia Cavazzoni, the head of FDA’s drug evaluation unit.

The sudden departure of Peter Marks, MD, from the FDA has prompted a chorus of criticism and despair from industry leaders and trade organizations.

That fear was heightened last month when Patrizia Cavazzoni, MD, resigned as director of the FDA’s Center for Drug Evaluation and Research (CDER), and returned to Pfizer to become its chief ...

<p>Revolving door is a VERY polite term for Patrizia Cavazzoni's moves. Then again, she has a 25-year history of picking Big Pharma over vulnerable patients. She'll fit right in with Scott ...

Pfizer hired ex-FDA deputy Patrizia Cavazzoni as its chief medical officer. Cavazzoni was the former head of drug regulation at the FDA. (Endpoints News) The Trump administration has moved to rehire ...

The former head of the Food and Drug Administration’s (FDA) drug division is joining Pfizer as its chief medical officer, the company announced Monday. Patrizia Cavazzoni was formerly director ...

Pfizer on Monday named the former head of the U.S. health regulator's drug evaluation unit, Patrizia Cavazzoni, as its chief medical officer, bringing back an industry veteran to lead its ...